NCT07833774Not yet recruiting
AI-enhanced Heart MRI for Evaluating Blood Flow
High-resolution AI-Driven Whole-Heart Perfusion MRI
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
This study will compare the standard MRI protocol with an advanced MRI protocol for the assessment of ischemic heart disease. The goal is to evaluate whether the advanced protocol provides comparable or improved diagnostic performance relative to the standard approach.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 16 Sept 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 31 Aug 2027
- Lead sponsor
- IRCCS San Raffaele
- Diseases
- Coronary artery disease
- NCT number
- NCT07833774
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Sept 2026 to the primary completion date, 31 Aug 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Refused to consent
- Claustrophobia
- Metal prosthesis potentially affecting image quality
Who the study is looking for
- Consecutive adults (≥18 y.o.) admitted to the UO for cardiac MRI with or without stress
Age in the registry: 18 years to - · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.